BioSpace News Archive

FibroBiologics, a clinical stage company developing fibroblast-based therapeutic solutions for chronic diseases, today announced the appointment of Hamid Khoja, Ph.D. as Chief Scientific Officer.

The global point of care diagnostics market is expected to reach US$ 70.89 Bn in 2027 from US$ 26.60 Bn in 2018.

The OTCQB is the venture tier of OTC Markets on which 11,000 U.S. and global securities trade.

Checkpoint Surgical, Inc. has announced an expansion of their intraoperative nerve care product line with the introduction of the NeuroShield® Chitosan Nerve Wrap.

Immune-Onc Therapeutics, Inc. (“Immune-Onc”), today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for IO-108, a novel antagonist antibody targeting Leukocyte Immunoglobulin-Like Receptor B2 (LILRB2, also known as ILT4) for the treatment of solid tumors.

Adial Pharmaceuticals, Inc. today announced it will host a conference call at 11:00 A.M. Eastern Time on Friday, August 20, 2021 to provide a clinical update and discuss the latest business developments.

Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer, reported recent business progress and second quarter financial results.